← Evidence map

TrialNeuropsychiatric disease and treatment2025

Reliability and Validity of the Chinese Version of the Frequency, Intensity, and Burden of Side Effects Rating (FIBSER) in Patients with Major Depressive Disorder-a Cross-Cultural Adaptation Study.

Na Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025

this papercites it

Reliability and Validity of the Chinese Version of the Frequency, Intensity, and Burden of Side Effects Rating (FIBSER) in Patients with Major Depressive Disorder-a Cross-Cultural Adaptation Study. | OpenQuestion